08:30-08:40

FP-01

Intravitreal triamcinolone acetonide (TA) versus bevacizumab (Avastin) for macular edema due to retinal vein occlusion

比較以玻璃體內注射triamcinolone acetonide或bevacizumab(Avastin)治療因視網膜靜脈阻塞而導致的黃斑部水腫的成效

鄭凱駿、吳文權

08:40-08:50

FP-02

The effect of intravitreous injection with Triamcinolone compare to bevacizumab to diabetic macular edema (DME)

針對糖尿病黃斑部水腫Triamcinolone及bevacizumab之治療效果比較

陳矜芸、吳文權

08:50-09:00

FP-03

Intravitreal Bevacizumab Injection for Branch and Central Retinal Vein Occlusion – 1 Year Follow Up

以玻璃體內注射Bevacizumab治療分支及中央視網膜靜脈阻塞之一年追蹤

陳彥廷、陳珊霓

09:00-09:10

FP-04

Efficacy of intravitreal benacizumab (Avastin) for polypoidal choroidal vasculopathy

蔡曉萱、陳世真、劉怜瑛、李鳳利

09:10-09:20

FP-05

Intravitreal injection of Bevacizumab for Choroidal Neovascularization in Pathologic Myopia

眼內Bevacizumab注射治療高度近視合併脈絡膜新生血管

陳勇仁、吳佩昌

09:20-09:30

FP-06

Avastin and long acting gas for early vitreous clear-up after vitrectomy for active diabetic proliferation

Avastin及長效氣體對增殖性糖尿病病變術中及術後玻璃體出血影響之研究

楊中美、葉伯廷、王宗仁、陳慕師

09:30-09:40

FP-07

Avastin pretreatment for reducing intraoperative and postoperative preretinal hemorrhage in primary diabetic vitrectomy with silicone oil infusion

術前Avastin對糖尿病視網膜病變患者玻璃體切除合併矽油灌注之影響

楊中美、林友祺、葉伯廷、楊長豪、王宗仁